medisourceasia.com logo

Market

Trendz  & Analysis


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

STRENGTHS
  • Strong self-reliant and vibrant R & D base for process technology. 

  • Ability to respond quickly to new demands and needs. 

  • Most of the important pharma companies are highly vertically integrated. 

  • Many units of the industry have world class manufacturing plants following GMP, approved by the FDCAs of many developed countries, including US-FDA. 

  • Indian industry is emerging as an innovative, low- cost producer of quality medicines. 

  • Practically all the commonly needed drugs are readily available in India based largely on indigenous production. 

  • Prices which are lowest in the world [which were highest in the 60s], which is especially important for Indian economic setting. 

  • Any new drug introduced abroad is made available in the country by indigenous production in a relatively short time. 

  • Indian Pharma industry is a net exporter [from being a net importer in 60s]. 

  • Indian industry emerging as an important producer of cost-effective quality generic drugs in the world markets, with a presence in about 60 countries. 

  • Some units of the industry have now grown to a large enough size to be able to invest meaningfully in new drug discovery research. 

  • Recent events like export of Anti-HIV drugs to countries like South Africa by Cipla Limited and anti-anthrax antibiotics like Ciprofloxacin by Indian manufacturers gives tremendous boost to Indian Pharma Sector.

WEAKNESSES 

  • Neglected marketing in rural areas, where 70 per cent of India stays but consume only 20 per cent of drugs. 

  • India is the repository of knowledge of herbal drugs and rich resource of needed medicinal plants, and yet the pharma units have not contributed much to develop herbal modern medicines. 

  • Biotechnology based Industry is now a mature international industry with immense future prospects; Indian industry is very weak in this area. 

  • Small presence in New Drug Delivery System. 

  • Implementation of regulations and acts is very slow & cumbersome.

  • Instability of trained technical man power in the R & D sector 

  • Lack of strong interaction and cooperation between R&D institutions, Industry and academia

Advertisement

 


 

Archives

More...

Top

Back

Next